» Articles » PMID: 1985708

Percent Tumor Necrosis As a Predictor of Treatment Response in Canine Osteosarcoma

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 1991 Jan 1
PMID 1985708
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The percent tumor necrosis was determined in 200 dogs with spontaneously occurring osteosarcoma. One hundred dogs had no treatment before amputation or death. One hundred other dogs were treated with either radiation therapy alone (n = 23), intraarterial (IA) cisplatin alone (n = 16), intravenous (IV) cisplatin alone (n = 6), radiation therapy plus IA cisplatin (n = 47), or radiation therapy plus IV cisplatin (n = 8). Eighty-nine of these 100 dogs had their tumors resected 3 weeks after the end of therapy (6 weeks after the initiation of therapy) and replaced with a cortical bone allograft. Dogs with preoperative treatment were evaluated for local tumor control and time to metastasis. The mean percent tumor necrosis in untreated osteosarcoma was 26.8%. The mean percent tumor necrosis for dogs receiving radiation only, IA cisplatin only, and IV cisplatin only was 81.6%, 49.1% and 23.8%, respectively. The mean percent tumor necrosis for dogs receiving radiation therapy plus IA cisplatin or radiation therapy plus IV cisplatin was 83.7% and 78.2%, respectively. There was no significant difference between percent tumor necrosis in untreated osteosarcoma compared with those receiving IV cisplatin, but there was a significant increase in percent tumor necrosis with all other treatments. A mathematic model for the effect of cisplatin and radiation dose was developed using multiple regression analysis. The radiation dose calculated to cause at least 80% tumor necrosis was 42.2 Gy (95% confidence interval [CI], 38.0 to 47.6 Gy) when radiation was given alone and 28.1 Gy (95% CI, 21.3 to 36.6 Gy) when radiation was combined with IA cisplatin. Areas of viable tumor tended to be most frequent adjacent to the articular cartilage and in the joint capsule. Percent tumor necrosis was strongly predictive for local tumor control; 28 of 32 dogs with greater than 80% tumor necrosis had local control, and only eight of 29 dogs with less than 79% tumor necrosis had local control (P = 0.0047). There was no correlation between percent tumor necrosis and time to metastasis.

Citing Articles

Fracture rate and time to fracture in dogs with appendicular osteosarcoma receiving finely fractionated compared to coarsely fractionated radiation therapy: A single institution study.

Norquest C, Maitz C, Keys D, Moore M, Bryan J, Ehling T Vet Med Sci. 2022; 8(3):1013-1024.

PMID: 35263506 PMC: 9122396. DOI: 10.1002/vms3.782.


Prospective clinical trial testing COXEN-based gene expression models of chemosensitivity in dogs with spontaneous osteosarcoma.

Gustafson D, Collins K, Fowles J, Ehrhart E, Weishaar K, Das S Cancer Chemother Pharmacol. 2021; 88(4):699-712.

PMID: 34263337 DOI: 10.1007/s00280-021-04325-y.


Outcome and prognosis for canine appendicular osteosarcoma treated with stereotactic body radiation therapy in 123 dogs.

Martin T, Griffin L, Custis J, Ryan S, Lafferty M, Boss M Vet Comp Oncol. 2021; 19(2):284-294.

PMID: 33403752 PMC: 8356246. DOI: 10.1111/vco.12674.


Pamidronate functionalized nanoconjugates for targeted therapy of focal skeletal malignant osteolysis.

Yin Q, Tang L, Cai K, Tong R, Sternberg R, Yang X Proc Natl Acad Sci U S A. 2016; 113(32):E4601-9.

PMID: 27457945 PMC: 4987772. DOI: 10.1073/pnas.1603316113.


Evaluation of intraarterial and intravenous cisplatin chemotherapy in the treatment of metastatic osteosarcoma using an orthotopic xenograft mouse model.

Robl B, Botter S, Pellegrini G, Neklyudova O, Fuchs B J Exp Clin Cancer Res. 2016; 35(1):113.

PMID: 27421768 PMC: 4947253. DOI: 10.1186/s13046-016-0392-1.